ÇѸ²´ëÇб³¼º½Éº´¿ø

°­Áر¸ ±³¼ö

031-380-3700
  • Áø·á°ú ³»ºÐºñ³»°ú

Àü¹®Áø·áºÐ¾ß

´ç´¢º´, °©»ó¼±Áúȯ, °ñ´Ù°øÁõ, ³úÇϼöü, ºÎ½Å

ÀüÈ­ ¿¹¾à 1577-1801
±³¼ö´Ô»çÁø

(ÁÖ°£) Áø·á½Ã°£Ç¥ (2022-08-15 ~ 2022-08-20)

Áø·á½Ã°£Ç¥
Áø·á½Ã°£ ¿ù È­ ¼ö ¸ñ ±Ý Åä
¿ÀÀü ¿Ü·¡Áø·á¿Ü·¡Áø·á¿Ü·¡Áø·á
¿ÀÈÄ ¿Ü·¡Áø·á
±³¼ö´Ô »çÁø

±âº»Á¤º¸

ÇзÂ

ÇзÂ

ÇѾç´ëÇб³ Àǰú´ëÇÐ Á¹¾÷

ÇѾç´ëÇб³ Àǰú´ëÇÐ ¹Ú»ç

°æ·Â

°æ·Â

ÇѾç´ëÇб³ ±¸¸®º´¿ø ³»ºÐºñ³»°ú ÀüÀÓÀÇ

Çö) ÇѸ²´ëÇб³¼º½Éº´¿ø ³»ºÐºñ³»°ú ±³¼ö´ë¿ì

ÇÐȸȰµ¿

ÇÐȸȰµ¿

´ëÇÑ´ç´¢º´ÇÐȸ ¿ªÇмÒÀ§¿øÈ¸ À§¿ø(2008-ÇöÀç)

´ëÇÑ´ç´¢º´ÇÐȸ 40Áֳ⠱â³ä»ç¾÷´Ü À§¿ø(08)

´ëÇÑ´ç´¢º´ÇÐȸ ±³À°À§¿øÈ¸ °£¼­(08-ÇöÀç)

´ëÇÑ´ç´¢º´ÇÐȸ ±³À°ÀÚ°ü¸®À§¿øÈ¸ À§¿ø(08-ÇöÀç)

´ëÇÑ´ç´¢º´ÇÐȸ È«º¸À§¿øÈ¸ À§¿ø(06-07)

³í¹®

Lipid indices as simple and clinically useful surrogate markers for insulin resistance in the U.S. population (Scientific Reports)

Effect of Sarcopenia and Body Shape on Cardiovascular Disease According to Obesity Phenotypes (Diabetes and Metabolism Journal)

Heat Shock Protein 90 Inhibitors AUY922, BIIB021 and SNX5422 Induce Bim-mediated Death of Thyroid Carcinoma Cells (ANTICANCER RESEARCH)

Z-score of the log-transformed A Body Shape Index predicts low muscle mass in population with abdominal obesity: The U.S: The Korea National Health and Nutrition Examination Survey (PLoS ONE)

Effect of body shape on the development of cardiovascular disease in individuals with metabolically healthy obesity (Medicine)

Relationships between Thigh and Waist Circumference, Hemoglobin Glycation Index, and Carotid Plaque in Patients with Type 2 Diabetes (Endocrinology and Metabolism)

Underweight Increases the Risk of End-Stage Renal Diseases for Type 2 Diabetes in Korean Population: Data From the National Health Insurance Service Health Checkups 2009-2017 (DIABETES CARE)

Evodiamine in combination with histone deacetylase inhibitors has synergistic cytotoxicity in thyroid carcinoma cells (ENDOCRINE)

Evodiamine Suppresses Survival, Proliferation, Migration and Epithelial?Mesenchymal Transition of Thyroid Carcinoma Cells / ^^¿µ¹® Á¦¸ñÀ» ¹Ýµå½Ã ±âÀçÇϽñ⠹ٶø´Ï´Ù. (Anticancer Res)

Gemigliptin, a novel dipeptidyl peptidase-IV inhibitor, exerts a synergistic cytotoxicity with the histone deacetylase inhibitor PXD101 in thyroid carcinoma cells (JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION)
(2013) ´ç´¢º´ ±³À° Áöħ¼­ (°ñµå±âȹ)

ºñ¸¸Ä¡·á Áöħ 2012 (´ëÇѺñ¸¸ÇÐȸ)

´ëÇѳ»ºÐºñÇÐȸ °¡À̵å¶óÀÎ(¸»´Üºñ´ëÁõ) (¿¥¿¥ÄÉÀÌÄ¿¹Â´ÏÄÉÀ̼ÇÁî)